Bnp Paribas Asset Management Holding S.A. Catalent, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.4 Billion
- Q3 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Catalent, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 575,446 shares of CTLT stock, worth $36.5 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
575,446
Previous 842,136
31.67%
Holding current value
$36.5 Million
Previous $47.4 Million
26.39%
% of portfolio
0.09%
Previous 0.12%
Shares
17 transactions
Others Institutions Holding CTLT
# of Institutions
406Shares Held
145MCall Options Held
571KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$473 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$406 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$287 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...